Business Description
Bangkok Lab and Cosmetic PCL
ISIN : THB407010008
Description
Bangkok Lab and Cosmetic PCL are one of Thailand's comprehensive healthcare solutions groups. The principal activities of the Group are the manufacturing and distributing of pharmaceuticals and medicinal chemical products for human and animal It operates in a single line of business, namely pharmaceuticals and medicinal chemical products, The Group derives revenue from sales of goods and rendering of services.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.34 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.15 | |||||
Debt-to-EBITDA | 0.98 | |||||
Interest Coverage | 25.39 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.12 | |||||
Beneish M-Score | -2.69 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.6 | |||||
3-Year EBITDA Growth Rate | 9.1 | |||||
3-Year EPS without NRI Growth Rate | 11.4 | |||||
3-Year Book Growth Rate | 83.5 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 73.54 | |||||
9-Day RSI | 60.01 | |||||
14-Day RSI | 55.06 | |||||
3-1 Month Momentum % | 3.09 | |||||
6-1 Month Momentum % | 1.52 | |||||
12-1 Month Momentum % | -13.04 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.82 | |||||
Quick Ratio | 0.92 | |||||
Cash Ratio | 0.16 | |||||
Days Inventory | 239.09 | |||||
Days Sales Outstanding | 83.31 | |||||
Days Payable | 79.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 7.32 | |||||
Dividend Payout Ratio | 1.34 | |||||
Forward Dividend Yield % | 7.32 | |||||
5-Year Yield-on-Cost % | 7.4 | |||||
Shareholder Yield % | 5.58 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 57.95 | |||||
Operating Margin % | 11.92 | |||||
Net Margin % | 8.94 | |||||
EBITDA Margin % | 15.67 | |||||
FCF Margin % | -27.87 | |||||
OCF Margin % | 8.47 | |||||
ROE % | 8.69 | |||||
ROA % | 6.2 | |||||
ROIC % | 8.83 | |||||
3-Year ROIIC % | 2.6 | |||||
ROC (Joel Greenblatt) % | 12.47 | |||||
ROCE % | 10.28 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 15.65 | |||||
PE Ratio without NRI | 15.65 | |||||
PS Ratio | 1.43 | |||||
PB Ratio | 1.4 | |||||
Price-to-Tangible-Book | 1.43 | |||||
Price-to-Operating-Cash-Flow | 16.64 | |||||
EV-to-EBIT | 13.08 | |||||
EV-to-EBITDA | 9.94 | |||||
EV-to-Revenue | 1.55 | |||||
EV-to-FCF | -5.54 | |||||
Price-to-GF-Value | 0.77 | |||||
Price-to-Graham-Number | 1 | |||||
| Price-to-Net-Current-Asset-Value | 10.15 | |||||
Earnings Yield (Greenblatt) % | 7.65 | |||||
FCF Yield % | -19.29 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bangkok Lab and Cosmetic PCL Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ฿) | 1,644.829 | ||
| EPS (TTM) (฿) | 0.253 | ||
| Beta | 0.6584 | ||
| 3-Year Sharpe Ratio | -0.52 | ||
| 3-Year Sortino Ratio | -0.65 | ||
| Volatility % | 26.68 | ||
| 14-Day RSI | 55.06 | ||
| 14-Day ATR (฿) | 0.060887 | ||
| 20-Day SMA (฿) | 3.925 | ||
| 12-1 Month Momentum % | -13.04 | ||
| 52-Week Range (฿) | 3.64 - 5.2 | ||
| Shares Outstanding (Mil) | 600 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bangkok Lab and Cosmetic PCL Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bangkok Lab and Cosmetic PCL Stock Events
| Event | Date | Price (฿) | ||
|---|---|---|---|---|
| THB 0.040000 Cash Dividend | 2026-05-22 | 3.94 (+0.51%) | ||
| THB 0.050000 Cash Dividend | 2026-04-09 | 3.94 (+1.03%) | ||
| THB 0.100000 Cash Dividend | 2025-12-30 | 4.20 (+0.00%) | ||
| THB 0.100000 Cash Dividend | 2025-08-26 | 4.40 (+0.46%) | ||
| THB 0.090000 Cash Dividend | 2025-04-10 | 3.84 (-2.54%) | ||
| THB 0.060000 Cash Dividend | 2024-08-27 | 5.15 (+0.98%) |
Show
Entries
Bangkok Lab and Cosmetic PCL Frequently Asked Questions
What is Bangkok Lab and Cosmetic PCL(BKK:BLC)'s stock price today?
The current price of BKK:BLC is ฿3.96. The 52 week high of BKK:BLC is ฿5.20 and 52 week low is ฿3.64.
When is next earnings date of Bangkok Lab and Cosmetic PCL(BKK:BLC)?
The next earnings date of Bangkok Lab and Cosmetic PCL(BKK:BLC) is .
Does Bangkok Lab and Cosmetic PCL(BKK:BLC) pay dividends? If so, how much?
The Dividend Yield %  of Bangkok Lab and Cosmetic PCL(BKK:BLC) is 7.32% (As of Today), Highest Dividend Payout Ratio of Bangkok Lab and Cosmetic PCL(BKK:BLC) was 1.34. The lowest was 0.11. And the median was 0.45. The  Forward Dividend Yield % of Bangkok Lab and Cosmetic PCL(BKK:BLC) is 7.32%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Bangkok Lab and Cosmetic PCL
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers